LifeStent
LifeStent® and LifeStent® XL Vascular and Biliary Stent System
Features:
- FDA-approved for the SFA and full popliteal artery
- Longest lesion length indication (up to 240 mm)1
- Unique helical design
- Engineered for bending, compression, torsion
- Dynamic vessel conformability
- Improved lesion coverage with a single stent
About LifeStent® Vascular Stent
The LifeStent® Vascular Stent System has achieved lasting results over the long term, with sustained effectiveness up to three years, and treatment superiority over balloon angioplasty.2 As the only commercially available bare metal stent FDA-approved for the superficial femoral and popliteal arteries, the LifeStent® Vascular Stent has a history of proven performance. With its unique helical design, it is engineered for bending, compression, and torsion with dynamic vessel conformability. The LifeStent® Vascular Stent Systems, in varying sizes, have been studied in more than ten clinical trials in the United States and globally.3
The LifeStent® Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 – 6.5mm. The LifeStent® Vascular Stent is the only FDA-approved stent for the SFA and full popliteal artery.1The LifeStent® Vascular Stent is available in 5 mm, 6 mm, and 7 mm diameters; and 20 mm to 170 mm in length.
Additionally, the LifeStent® Solo™ Vascular Stent is available in 6 mm and 7 mm diameters and 200 mm in length. To learn more about the LifeStent® Solo™ Vascular Stent
1 As of August 2016
2 Laird et al. Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized Trial. J Endovasc Ther. 2012;19:1-9. The LifeStent® 5 mm diameter was not included in this trial.
3 RESILIENT I Trial, RESILIENT II Trial, E-TAGIUSS Trial, Retrospective Analysis of LifeStent® Vascular Stent Systems in the Treatment of Long-Segment Lesions, LifeStent® Vascular Stent Delivery System Study (LifeStent® 200 mm Trial),REALITY I Trial,REALITY II Trial, ETAP Trial, CONTINUUM Trial, and RELIABLE Trial. Additional trials ongoing.